je.st
news
UPDATE 2-FDA staff cautious about J&J's latest Xarelto application
2014-01-15 02:12:29| Biotech - Topix.net
The U.S. Food and Drug Administration appears skeptical that data submitted by Johnson & Johnson proves its anticoagulant Xarelto is effective in reducing the risk of further heart problems in patients who have recently suffered a heart attack.
Tags: latest
application
staff
update
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||